PMC:7279430 / 1551-2353 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"90","span":{"begin":9,"end":56},"obj":"Species"},{"id":"91","span":{"begin":58,"end":68},"obj":"Species"},{"id":"92","span":{"begin":250,"end":260},"obj":"Species"},{"id":"93","span":{"begin":298,"end":304},"obj":"Species"},{"id":"94","span":{"begin":603,"end":613},"obj":"Chemical"},{"id":"95","span":{"begin":90,"end":109},"obj":"Disease"},{"id":"96","span":{"begin":413,"end":421},"obj":"Disease"},{"id":"97","span":{"begin":473,"end":479},"obj":"Disease"},{"id":"98","span":{"begin":558,"end":578},"obj":"Disease"},{"id":"99","span":{"begin":674,"end":682},"obj":"Disease"}],"attributes":[{"id":"A90","pred":"tao:has_database_id","subj":"90","obj":"Tax:2697049"},{"id":"A91","pred":"tao:has_database_id","subj":"91","obj":"Tax:2697049"},{"id":"A92","pred":"tao:has_database_id","subj":"92","obj":"Tax:2697049"},{"id":"A93","pred":"tao:has_database_id","subj":"93","obj":"Tax:9606"},{"id":"A94","pred":"tao:has_database_id","subj":"94","obj":"MESH:C000606551"},{"id":"A95","pred":"tao:has_database_id","subj":"95","obj":"MESH:D012140"},{"id":"A96","pred":"tao:has_database_id","subj":"96","obj":"MESH:D007239"},{"id":"A97","pred":"tao:has_database_id","subj":"97","obj":"MESH:D003643"},{"id":"A98","pred":"tao:has_database_id","subj":"98","obj":"MESH:C000657245"},{"id":"A99","pred":"tao:has_database_id","subj":"99","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerging respiratory illness. The epidemic started in December 2019 in Wuhan, China, and has rapidly spread throughout China and the world and is now a global pandemic. SARS-CoV-2 can be efficiently transmitted among humans and has shown a high degree of morbidity and mortality [1,2]. As of April 20, 2020, the worldwide number of infected individuals was 2,544,792, with as many as 175,694 deaths [3]. There are currently no approved vaccines available for the prevention of SARS-CoV-2 infection and only just recently, remdesivir has received “emergency use authorization” for treatment of COVID-19 in the United States; therefore, there is an urgent demand for potential chemotherapeutic agents to treat this disease."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T21","span":{"begin":9,"end":56},"obj":"Disease"},{"id":"T22","span":{"begin":9,"end":42},"obj":"Disease"},{"id":"T23","span":{"begin":58,"end":66},"obj":"Disease"},{"id":"T24","span":{"begin":250,"end":258},"obj":"Disease"},{"id":"T25","span":{"begin":558,"end":566},"obj":"Disease"},{"id":"T26","span":{"begin":569,"end":578},"obj":"Disease"},{"id":"T27","span":{"begin":674,"end":682},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"The 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerging respiratory illness. The epidemic started in December 2019 in Wuhan, China, and has rapidly spread throughout China and the world and is now a global pandemic. SARS-CoV-2 can be efficiently transmitted among humans and has shown a high degree of morbidity and mortality [1,2]. As of April 20, 2020, the worldwide number of infected individuals was 2,544,792, with as many as 175,694 deaths [3]. There are currently no approved vaccines available for the prevention of SARS-CoV-2 infection and only just recently, remdesivir has received “emergency use authorization” for treatment of COVID-19 in the United States; therefore, there is an urgent demand for potential chemotherapeutic agents to treat this disease."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T6","span":{"begin":73,"end":74},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T7","span":{"begin":170,"end":173},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T8","span":{"begin":231,"end":232},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T9","span":{"begin":298,"end":304},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T10","span":{"begin":309,"end":312},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T11","span":{"begin":319,"end":320},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T12","span":{"begin":614,"end":617},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"The 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerging respiratory illness. The epidemic started in December 2019 in Wuhan, China, and has rapidly spread throughout China and the world and is now a global pandemic. SARS-CoV-2 can be efficiently transmitted among humans and has shown a high degree of morbidity and mortality [1,2]. As of April 20, 2020, the worldwide number of infected individuals was 2,544,792, with as many as 175,694 deaths [3]. There are currently no approved vaccines available for the prevention of SARS-CoV-2 infection and only just recently, remdesivir has received “emergency use authorization” for treatment of COVID-19 in the United States; therefore, there is an urgent demand for potential chemotherapeutic agents to treat this disease."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T30","span":{"begin":603,"end":613},"obj":"Chemical"}],"attributes":[{"id":"A30","pred":"chebi_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"}],"text":"The 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerging respiratory illness. The epidemic started in December 2019 in Wuhan, China, and has rapidly spread throughout China and the world and is now a global pandemic. SARS-CoV-2 can be efficiently transmitted among humans and has shown a high degree of morbidity and mortality [1,2]. As of April 20, 2020, the worldwide number of infected individuals was 2,544,792, with as many as 175,694 deaths [3]. There are currently no approved vaccines available for the prevention of SARS-CoV-2 infection and only just recently, remdesivir has received “emergency use authorization” for treatment of COVID-19 in the United States; therefore, there is an urgent demand for potential chemotherapeutic agents to treat this disease."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":90,"end":109},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002086"}],"text":"The 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerging respiratory illness. The epidemic started in December 2019 in Wuhan, China, and has rapidly spread throughout China and the world and is now a global pandemic. SARS-CoV-2 can be efficiently transmitted among humans and has shown a high degree of morbidity and mortality [1,2]. As of April 20, 2020, the worldwide number of infected individuals was 2,544,792, with as many as 175,694 deaths [3]. There are currently no approved vaccines available for the prevention of SARS-CoV-2 infection and only just recently, remdesivir has received “emergency use authorization” for treatment of COVID-19 in the United States; therefore, there is an urgent demand for potential chemotherapeutic agents to treat this disease."}

{"project":"LitCovid-sentences","denotations":[{"id":"T13","span":{"begin":0,"end":110},"obj":"Sentence"},{"id":"T14","span":{"begin":111,"end":249},"obj":"Sentence"},{"id":"T15","span":{"begin":250,"end":366},"obj":"Sentence"},{"id":"T16","span":{"begin":367,"end":484},"obj":"Sentence"},{"id":"T17","span":{"begin":485,"end":802},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerging respiratory illness. The epidemic started in December 2019 in Wuhan, China, and has rapidly spread throughout China and the world and is now a global pandemic. SARS-CoV-2 can be efficiently transmitted among humans and has shown a high degree of morbidity and mortality [1,2]. As of April 20, 2020, the worldwide number of infected individuals was 2,544,792, with as many as 175,694 deaths [3]. There are currently no approved vaccines available for the prevention of SARS-CoV-2 infection and only just recently, remdesivir has received “emergency use authorization” for treatment of COVID-19 in the United States; therefore, there is an urgent demand for potential chemotherapeutic agents to treat this disease."}

{"project":"2_test","denotations":[{"id":"32408699-32081636-52981834","span":{"begin":361,"end":362},"obj":"32081636"},{"id":"T17730","span":{"begin":361,"end":362},"obj":"32081636"}],"text":"The 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerging respiratory illness. The epidemic started in December 2019 in Wuhan, China, and has rapidly spread throughout China and the world and is now a global pandemic. SARS-CoV-2 can be efficiently transmitted among humans and has shown a high degree of morbidity and mortality [1,2]. As of April 20, 2020, the worldwide number of infected individuals was 2,544,792, with as many as 175,694 deaths [3]. There are currently no approved vaccines available for the prevention of SARS-CoV-2 infection and only just recently, remdesivir has received “emergency use authorization” for treatment of COVID-19 in the United States; therefore, there is an urgent demand for potential chemotherapeutic agents to treat this disease."}